Skip to main content
SpringerLink
Log in

High-Intensity-Focused Ultrasound for Prostate Cancer

  • Chapter
  • First Online:
Interventional Urology

Abstract

Prostate cancer is the most common cancer in males and the second-leading cancer-related cause of death in the Western world. Prostate-specific antigen (PSA) screening, and changes in the diagnostic pathway of prostate cancer, has resulted in proportionally more men being diagnosed with early-stage prostate cancer still confined to the prostate. Patients are faced with an overwhelming choice of treatment options to treat their disease. Standard options include radical prostatectomy (RP) and external-beam radiotherapy (ERBT) which, although provide good long-term cancer control, are associated with significant side effects affecting the quality of life of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375(15):1425–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, et al. Radical prostatectomy or watchful waiting in prostate cancer — 29-year follow-up. N Engl J Med. 2018;379(24):2319–29.

    Article  PubMed  Google Scholar 

  3. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. PRECISION Study Group Collaborators. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–77.

    Article  Google Scholar 

  4. Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 2019;20(1):100–109.

    Article  Google Scholar 

  5. Orczyk C, Emberton M, Ahmed HU. What tumours should we treat with focal therapy based on risk category, grade, size and location? Curr Opin Urol. 2015;25(3):212–9.

    Article  PubMed  Google Scholar 

  6. Murat F-JL, Gelet A. Current status of high-intensity focused ultrasound for prostate cancer: technology, clinical outcomes, and future. Curr Urol Rep. 2008;9(2):113–21.

    Article  PubMed  Google Scholar 

  7. Haar GT, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperth. 2007;23(2):89–104.

    Article  Google Scholar 

  8. Marberger M. Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation. Curr Opin Urol. 2007;17(3):194–9.

    Article  PubMed  Google Scholar 

  9. Dickinson L, Hu Y, Ahmed HU, Allen C, Kirkham AP, Emberton M, Barratt D. Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system. BJU Int. 2013;112(5):594–601.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R, Martin X, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol. 2007;51(2):381–7.

    Article  CAS  PubMed  Google Scholar 

  11. Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, Walter B. Eight years’ experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology. 2008;72(6):1329–33; discussion 1333–4

    Article  PubMed  Google Scholar 

  12. Crouzet S, Rebillard X, Chevallier D, Rischmann P, Pasticier G, Garcia G, Rouviere O, Chapelon JY, Gelet A. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol. 2010;58(4):559–66.

    Article  PubMed  Google Scholar 

  13. Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol. 2014;65(5):907–14.

    Article  PubMed  Google Scholar 

  14. Ripert T, Azémar MD, Ménard J, Barbe C, Messaoudi R, Bayoud Y, et al. Six years’ experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new ‘Stuttgart’ definition for biochemical failure. BJU Int. 2011;107(12):1899–905.

    Article  PubMed  Google Scholar 

  15. Pfeiffer D, Berger J, Gross AJ. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. BJU Int. 2012;110(11):1702–8.

    Article  PubMed  Google Scholar 

  16. Thüroff S, Chaussy C. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. J Urol. 2013;190(2):702–10.

    Article  PubMed  Google Scholar 

  17. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C, Gelet A. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol. 2008;53(6):1194–201.

    Article  PubMed  Google Scholar 

  18. Blana A, Robertson CN, Brown SC, Chaussy C, Crouzet S, Gelet A, et al. Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry. Prostate Cancer Prostatic Dis. 2012;15(3):256–9.

    Article  CAS  PubMed  Google Scholar 

  19. Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Murota A, Nagata Y. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int J Urol. 2009;16(11):881–6.

    Article  PubMed  Google Scholar 

  20. Shoji S, Nakano M, Nagata Y, Usui Y, Terachi T, Uchida T. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study. Int J Urol. 2010;17(8):715–9.

    Article  PubMed  Google Scholar 

  21. Inoue Y, Goto K, Hayashi T, Hayashi M. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer. Int J Urol. 2011;18(5):358–62.

    Article  PubMed  Google Scholar 

  22. Ahmed HU, Zacharakis E, Dudderidge T, Armitage JN, Scott R, Calleary J, et al. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer. 2009;101(1):19–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 2009;104(8):1058–62.

    Article  CAS  PubMed  Google Scholar 

  24. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 1995;55(15):3346–51.

    CAS  PubMed  Google Scholar 

  25. Beerlage HP, Thüroff S, Debruyne FM, Chaussy C, de la Rosette JJ. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology. 1999;54(2):273–7.

    Article  CAS  PubMed  Google Scholar 

  26. Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38(3):192–9.

    Article  PubMed  Google Scholar 

  27. Murat FJ, Cherasse A, Poissonnier L, Pricaz E, Kulisa MJY, Chapelon JY, et al. 854 Focal therapy of prostate cancer (PCA) with HIFU: influence on erectile dysfunction (ED) (abstract 854). Eur Urol Suppl. 2009;8(4):334.

    Article  Google Scholar 

  28. Ahmed HU, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol. 2011;185(4):1246–54.

    Article  CAS  PubMed  Google Scholar 

  29. Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ahmed HU, Dickinson L, Charman S, Weir S, McCartan N, Hindley RG, et al. Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a Prospective Development Study. Eur Urol. 2015;68(6):927–36.

    Article  PubMed  Google Scholar 

  31. Feijoo ER, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F, et al. Focal high-intensity focused ultrasound targeted hemiablation for unilateral prostate cancer: a prospective evaluation of oncologic and functional outcomes. Eur Urol. 2016;69(2):214–20.

    Article  PubMed  Google Scholar 

  32. Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L. Oncologic and functional outcomes of partial gland ablation with high intensity focused ultrasound for localized prostate cancer. J Urol. 2019;201(1):113–9.

    Article  PubMed  Google Scholar 

  33. Rischmann P, Gelet A, Riche B, Villers A, Pasticier G, Bondil P, et al. Focal high intensity focused ultrasound of unilateral localized prostate cancer: a prospective multicentric hemiablation study of 111 patients. Eur Urol. 2017;71(2):267–73.

    Article  PubMed  Google Scholar 

  34. Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T, et al. A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer. Eur Urol. 2018;74(4):422–9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, et al. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. BJU Int. 2019;124(3):431–40.

    Article  PubMed  Google Scholar 

  36. Faure Walker NA, Norris JM, Shah TT, Yap T, Cathcart P, Moore CM, Ahmed HU, Emberton M, Minhas S. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: a systematic review. Urol Oncol Semin Orig Investig. 2018;36(2):67–76.

    Google Scholar 

  37. Sivaraman A, Barret E. Focal therapy for prostate cancer: an “à la carte” approach. Eur Urol. 2016;69(6):973–5.

    Article  PubMed  Google Scholar 

  38. Le Nobin J, Rosenkrantz AB, Villers A, Orczyk C, Deng F-M, Melamed J, et al. Image guided focal therapy for magnetic resonance imaging visible prostate cancer: defining a 3-dimensional treatment margin based on magnetic resonance imaging histology co-registration analysis. J Urol. 2015;194(2):364–70.

    Article  PubMed  PubMed Central  Google Scholar 

  39. El Fegoun AB, Barret E, Prapotnich D, Soon S, Cathelineau X, Rozet F, et al. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. Int Braz J Urol. 2011;37(2):213–9; discussion 220–2

    Article  PubMed  Google Scholar 

  40. Van Velthoven R, Aoun F, Limani K, Narahari K, Lemort M, Peltier A. Primary zonal high intensity focused ultrasound for prostate cancer: results of a prospective phase iia feasibility study. Prostate Cancer. 2014;2014:756189. Erratum in: Prostate Cancer. 2014;2014:640859

    PubMed  PubMed Central  Google Scholar 

  41. Zelefsky MJ, Reuter VE, Fuks Z, Scardino P, Shippy A. Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J Urol. 2008;179(4):1368–73; discussion 1373

    Article  PubMed  PubMed Central  Google Scholar 

  42. Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003;57(4):915–28.

    Article  PubMed  Google Scholar 

  43. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008;112(2):307–14.

    Article  PubMed  Google Scholar 

  44. Lee WR, Hanks GE, Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol. 1997;15(1):230–8.

    Article  CAS  PubMed  Google Scholar 

  45. Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2009;55(3):640–7.

    Article  PubMed  Google Scholar 

  46. Zacharakis E, Ahmed HU, Ishaq A, Scott R, Illing R, Freeman A, et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int. 2008;102(7):786–92.

    Article  PubMed  Google Scholar 

  47. Gelet A, Chapelon JY, Poissonnier L, Bouvier R, Rouvière O, Curiel L, et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology. 2004;63(4):625–9.

    Article  PubMed  Google Scholar 

  48. Crouzet S, Murat FJ, Pommier P, Poissonnier L, Pasticier G, Rouviere O, et al. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. Radiother Oncol. 2012;105(2):198–202.

    Article  PubMed  Google Scholar 

  49. Song W, Jung US, Suh YS, Jang HJ, Sung HH, Jeon HG, et al. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapy. Korean J Urol. 2014;55(2):91–6.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Ahmed HU, Cathcart P, McCartan N, Kirkham A, Allen C, Freeman A, Emberton M. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer. 2012;118(17):4148–55.

    Article  PubMed  Google Scholar 

  51. Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, et al. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study. BJU Int. 2014;114(4):532–40.

    Article  PubMed  Google Scholar 

  52. Kanthabalan A, Peters M, Van Vulpen M, McCartan N, Hindley RG, Emara A, et al. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer. BJU Int. 2017;120(2):246–56.

    Article  CAS  PubMed  Google Scholar 

  53. Peters M, Kanthabalan A, Shah TT, McCartan N, Moore CM, Arya M, et al. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses. Urol Oncol Semin Orig Investig. 2018;36(1):13.e1–13.e10.

    Google Scholar 

  54. Gerber GS, Thisted RA, Scardino PT, Frohmuller HG, Schroeder FH, Paulson DF, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 1996;276(8):615–9.

    Article  CAS  PubMed  Google Scholar 

  55. Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, et al. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol. 2006;24(3):273–80.

    Article  PubMed  Google Scholar 

  56. Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi AE. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol Oncol. 2012;30(5):577–83.

    Article  PubMed  Google Scholar 

  57. Hayashi M, Shinmei S, Asano K. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Int J Urol. 2007;14(11):1048–50.

    Article  PubMed  Google Scholar 

  58. Potters L, Morgenstern C, Calugaru E, Fearn P, Jassal A, Presser J, Mullen E. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2005;173(5):1562–6.

    Article  PubMed  Google Scholar 

  59. Yutkin V, Ahmed HU, Donaldson I, McCartan N, Siddiqui K, Emberton M, Chin JL. Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy. Urology. 2014;84(5):1157–62.

    Article  PubMed  Google Scholar 

  60. Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol. 2006;24(5):585–90.

    Article  PubMed  Google Scholar 

  61. Stabile A, Orczyk C, Giganti F, Moschini M, Allen C, Punwani S, et al. The role of percentage of prostate-specific antigen reduction after focal therapy using high-intensity focused ultrasound for primary localised prostate cancer. Results from a large multi-institutional series. Eur Urol. 2020;78(2):155–60.

    Article  CAS  PubMed  Google Scholar 

  62. Ben Cheikh A, Girouin N, Ryon-Taponnier P, Mège-Lechevallier F, Gelet A, Chapelon JY, et al. MR detection of local prostate cancer recurrence after transrectal high-intensity focused US treatment: preliminary results. J Radiol. 2008;89(5 Pt 1):571–7. (Article in French)

    Article  CAS  PubMed  Google Scholar 

  63. Rouvière O, Girouin N, Glas L, Ben Cheikh A, Gelet A, Mège-Lechevallier F, et al. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI. Eur Radiol. 2010;20(1):48–55.

    Article  PubMed  Google Scholar 

  64. Rouvière O, Lyonnet D, Raudrant A, Colin-Pangaud C, Chapelon JY, Bouvier R, et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol. 2001;40(3):265–74.

    Article  PubMed  Google Scholar 

  65. Susani M, Madersbacher S, Kratzik C, Vingers L, Marberger M. Morphology of tissue destruction induced by focused ultrasound. Eur Urol. 1993;23(Suppl 1):34–8.

    Article  PubMed  Google Scholar 

  66. Rouvière O, Gelet A, Crouzet S, Chapelon JY. Prostate focused ultrasound focal therapy--imaging for the future. Nat Rev Clin Oncol. 2012;9(12):721–7.

    Article  PubMed  Google Scholar 

  67. Dickinson L, Ahmed HU, Hindley RG, McCartan N, Freeman A, Allen C, et al. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Urol Oncol. 2017;35(1):30.e9–30.e15.

    Article  CAS  Google Scholar 

  68. Thompson JE, Sridhar AN, Tan WS, Freeman A, Haider A, Allen C, et al. Pathological findings and magnetic resonance imaging concordance at salvage radical prostatectomy for local recurrence following partial ablation using high intensity focused ultrasound. J Urol. 2019;201(6):1134–43.

    Article  PubMed  Google Scholar 

  69. Marconi L, Stonier T, Tourinho-Barbosa R, Moore C, Ahmed HU, Cathelineau X, et al. Robot-assisted radical prostatectomy after focal therapy: oncological, functional outcomes and predictors of recurrence. Eur Urol. 2019;76(1):27–30.

    Article  PubMed  Google Scholar 

  70. Nunes-Silva I, Barret E, Srougi V, Baghdadi M, Capogrosso P, Garcia-Barreras S, et al. Effect of prior focal therapy on perioperative, oncologic and functional outcomes of salvage robotic assisted radical prostatectomy. J Urol. 2017;198(5):1069–76.

    Article  PubMed  Google Scholar 

  71. Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, et al. An exploratory study of dose escalation vs standard focal high-intensity focused ultrasound for treating nonmetastatic prostate cancer. J Endourol. 2020;34(6):641–6.

    Article  PubMed  Google Scholar 

  72. Tsakiris P, Thüroff S, de la Rosette J, Chaussy C. Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. J Endourol. 2008;22(2):221–9.

    Article  PubMed  Google Scholar 

  73. Ahmed HU, Ishaq A, Zacharakis E, Shaw G, Illing R, Allen C, et al. Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy. BJU Int. 2009;103(3):321–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgery and Interventional Sciences, University College London, London, UK

    Clement Orczyk & Mark Emberton

  2. Department of Urology, University College London Hospitals NHS Trust, London, UK

    Clement Orczyk & Mark Emberton

Authors
  1. Clement Orczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Emberton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clement Orczyk .

Editor information

Editors and Affiliations

  1. Urology and Radiology, Lenox Hill Hospital, New York, NY, USA

    Ardeshir R. Rastinehad

  2. Vascular & Interventional Radiology, North Shore Long Island Jewish Health System, New Hyde Park, NY, USA

    David N. Siegel

  3. National Cancer Institute & Clinica, Bethesda, MD, USA

    Bradford J. Wood

  4. Lefrak Center for Robotic Surgery, Weill Cornell Medicine, New York, NY, USA

    Timothy McClure

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Orczyk, C., Emberton, M. (2021). High-Intensity-Focused Ultrasound for Prostate Cancer. In: Rastinehad, A.R., Siegel, D.N., Wood, B.J., McClure, T. (eds) Interventional Urology . Springer, Cham. https://doi.org/10.1007/978-3-030-73565-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73565-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73564-7

  • Online ISBN: 978-3-030-73565-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation